About Bionime

Bionime was established in April 2003 with the goal of improving the lives of people with diabetes through better self-monitoring. Bionime is focused on designing and manufacturing accurate medical testing equipment. Our first product line started out with accurate blood glucose monitors that mimic the capabilities state-of-the-art devices usually found in healthcare research facilities. Our product line has since expanded into multiple different Self-Monitoring Blood Glucose (SMBG) Systems.

With the integration of top-tier scientific expertise, Bionime has successfully commercialized many patented technologies. This includes our unique Validus technology test strips which enables patients to receive accurate readings on-the-go.

Today Bionime operates in most major markets including Europe, the Middle East, Africa, the Americas, and Asia. Our products have received outstanding international recognition in clinical tests and by well-known journals. Our products continue to be distributed worldwide with great success.




Vision

With our “peace of mind“ medical devices, we offer solutions to patients to help them accurately manage and control their own health.



Philosophy

Better health for more people

Our philosophy is to provide products of the highest quality both to people in need and their caregivers to help them easily manage their day-to-day health. With this foundation in mind, Bionime has successfully integrated different technologies, combining Swiss designs and made-in-Taiwan quality assurance, to provide a continuous supply of world-class diagnostic solutions to our customers around the world. Our unique product designs provide accurate, precise test results, deliver a superb user experience, build customer satisfaction, foster trust, and ultimately help us fulfil our vision of better health for more people. With this philosophy in mind, we will continue striving to ensure good health and a quality life is possible for everyone.

 

 

Corporate Milestones

Bionime together with qualified experts in the field of diabetes have initiated and completed several SMBG patents during the last few years. Nevertheless, innovation and creativity continue to characterize Bionime's efforts in the SMBG field.

May
Launches GM700 Pro 2 for easy data management and synchronization within hospitals
Feb
Bionime Singapore established
Feb
Bionime Indonesia established
Nov
Awarded the Taiwan Excellence Award (Rightest Blood Glucose Ecosystem)
Nov
Rightest CARE Total Solution System has won the 2019 Taiwan Excellence Award
Mar
Established Malaysian subsidiary - Bionime (Malaysia) SDN BHD
Feb
Acquired ISO 27001:2013 information security management system certification
Oct
Meets ISO 13485:2016 certification of quality management systems for medical devices.
July
Launches Rightest CARE App, the blood glucose self-management App in Google Play and App Store.
July
GM700SB Bluetooth glucometer has been first released in Taiwan.
June
Releases new Rightest logo Rightest logo 
Feb
GM700 Pro has won the Taiwan Excellence Award.
Aug
Certified by Brazil's National Health Surveillance Agency and received ANVISA Certificate
Apr
Successfully obtained Good Manufacturing Practices (GMP) certification from the Ministry of Health and Welfare, Republic of China (Taiwan) for additional products including uric acid and cholesterol detections.
Dec
Received capital injection by private placement of Dongbao Pharmaceutical Co., Ltd.
Apr
Obtained new patent in China is regarding "Insulin measuring pen with biological sensors".
Jan
Established subsidiary in Pingtan, China
Dec
Received new patent in Germany for “Measuring Device for an Analyte”.
Jun
Members of the Diplomatic and Economic Representatives in Taiwan Visit Bionime for Exchange International Business and Bionime’s Competitive Advantages
Jan
GM720 won the Taiwan Excellence Award
Oct
GM720 won the National Industrial Innovation Award
Sep
GD500 won National Invention and Creation Award
Sep
Pass Taiwan GMP certification
Mar
Mylife Unio Won Reddot Design Award
Mar
New Building & Factory completion
Dec
New Product “Mylife Unio” shipped to European Market
Jan
GE Selects Bionime to Launch Innovative Diabetes Solutions
Dec
Bionime acquires the Innovation Award from Taiwan Ministry Economic Affair.
Sep
BIONIME has passed certification of OHSAS18001.
Jul
Acquisition land property for extending operation
Jul
Pass Taiwan AEO Certification
Mar
Strategic global cooperation with GE during term of Licensing Agreement in diabetes technology.
Dec
Become a public company and traded officially as a hi-tech company on the TWSE.
Sep
Granted the highest award of Taipei Biotech competition.
Aug
Approved to apply a high-tech list company by Industrial Development Bureau, Ministry of Economic Affairs.
Feb
Set up Bionime Australia Pty Limited.
Jul
Granted SFDA of RightestGM100, 110.
May
Launch of Rightest GM550 in Europe.
Apr
Pass KGMP audit.
Jan
Listed on Emerging Stock Market (#4737)
Oct
In strategic alliance with Ypsomed, a Switzerland-based solution provider of injection system for diabetes treatment.
Sep
Granted FDA 510(K) of Rightest GM100, 110.
Aug
First shipment of ODM products.
Mar
Launch new Lancing Device to the market.
Feb
Set up BIONIME USA Corporation.
Aug
Passed ISO 13485 and CMDCAS audit.
July
Passed TNO Certification.
Mar
Launch Rightest GM100.
Feb
Set up BIONIME (ShenZhen) Co., Ltd.
Aug
Granted China SFDA of Rightest GM300 Aug.
Jun
Passed Taiwan GMP Certification Jun.
May
Launch Rightest GM300
Apr
Set up BIONIME GmbH Switzerland in Apr.
Jan
Granted FDA 510(K) of Rightest GM300.
Dec
Set up Bionime Corporation.
Nov
Granted CE Certification and passed ISO13485 Certification.
Oct
The development of the first generation of blood glucose meter was completed.
Apr
BIONIME was founded at Dali City, Taichung County.

 

 

Global Locations

BIONIME CORPORATION

  • TEL:+886 4 2369 2388
  • FAX:+886 4 2261 7586
  • Address:No.100, Sec. 2, Daqing St., South Dist., Taichung City 40242, Taiwan (R.O.C.)
  • E-mail:info@bionime.com
  • Toll-Free:0800 371 688
  • Service Hours:Mon - Fri, 8:30 am - 5:30 pm

Bionime GmbH (Switzerland)

Bionime USA Corporation

Bionime (Malaysia) SDN BHD

Bionime (Pingtan) Co., Ltd.

  • TEL:+86 591 6252 3167
  • FAX:+86 591 6252 3166
  • E-mail:info@bionime.com
  • Address:Taiwan Pioneer Park, Pingtan Comprehensive Experimental Area, Pingtan County, Fuzhou City, Fujian Province, China

Bionime (Shenzhen) Co., Ltd.